Basilea announces distribution agreement with JSC Lancet for antibiotic Zevtera® (ceftobiprole) covering Russia and the Eurasian Economic Union
Ad hoc announcement pursuant to Art. 53 LR Basel, Switzerland, July 14, 2021 Basilea Pharmaceutica…
Ad hoc announcement pursuant to Art. 53 LR Basel, Switzerland, July 14, 2021 Basilea Pharmaceutica…
July 14, 2021 Breda, the Netherlands – argenx (Euronext & Nasdaq: ARGX), a global immunology…
NEWTON, Mass., July 13, 2021 (GLOBE NEWSWIRE) — Allena Pharmaceuticals, Inc. (NASDAQ: ALNA), a late-stage, biopharmaceutical…
BOSTON, July 13, 2021 (GLOBE NEWSWIRE) — Imara Inc. (the “Company”) (Nasdaq: IMRA), a clinical-stage…
HAMPTON, N.J., July 13, 2021 (GLOBE NEWSWIRE) — Celldex Therapeutics, Inc. (“Celldex” or the “Company”)…
CONSHOHOCKEN, Pa., July 13, 2021 (GLOBE NEWSWIRE) — Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL) announced today its…
Reduced average 30-day heart failure related costs by $17,753 (p<0.0001) per study subject in FUROSCIX®…
EMERYVILLE, Calif., July 13, 2021 (GLOBE NEWSWIRE) — Berkeley Lights, Inc. (Nasdaq: BLI), a leader…
REDWOOD CITY, Calif., July 13, 2021 (GLOBE NEWSWIRE) — Seer, Inc. (Nasdaq: SEER), a life…
Company announcement – No. 46 / 2021 Zealand Pharma A/S – Transaction Under Share Repurchase…
BOSTON, July 13, 2021 (GLOBE NEWSWIRE) — Imara Inc. (the “Company”) (Nasdaq: IMRA), a clinical-stage…
Initiated Phase 1 trial of lead program NX-2127 in patients with relapsed or refractory B-cell…
Nordic Oil, a market leader in the European CBD industry, has launched its first ever…
SpineX’s Proprietary SCONE™ Device Offers New Hope to Families of Children with CP SCONE Device…
ImCheck Publishes Seminal Paper in Cell Reports Elucidating How Butyrophilins Activate Vγ9Vδ2 T cell Function…
Infant Bacterial Therapeutics AB (publ) today announced that Marie-Louise Alamaa has been appointed Chief Financial…
Altadena, CA, July 13, 2021 (GLOBE NEWSWIRE) — Lixte Biotechnology Holdings, Inc. (Nasdaq: LIXT) (“Lixte”…
Positive Results from Phase 2 Presbyopia (VEGA-1) and Phase 3 Reversal of Mydriasis (MIRA-2) Studies…
WOBURN, Mass., July 13, 2021 (GLOBE NEWSWIRE) — Yield10 Bioscience, Inc. (Nasdaq: YTEN), an agricultural…
OSTEOAMP SELECT Flowable from Bioventus A demonstration of how OSTEOAMP SELECT Flowable can be easily…